Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models
Lindsay J. Talbot(St. Jude Children's Research Hospital), Christopher DeRenzo(St. Jude Children's Research Hospital)
Cited by 28
Related Papers
CD47 expression is critical for CAR T-cell survival in vivo
|Journal for ImmunoTherapy of Cancer|2023|34
A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation
|Journal of Experimental & Clinical Cancer Research|2024|5